Fundraising FoxMassVentures — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
BiotechCambridge, US
Michael Cardone(Executive Officer, Director)in
Leuko develops a noninvasive white blood cell monitor to track neutropenia risk in cancer patients and others undergoing treatment.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBoston, US
Ian Butterworth(Chief Technology Officer)inAurelien Bourquard(Chief Data Scientist)inAlvaro Sanchez-Ferro(Chief Medical Officer)inCarlos Castro-Gonzalez(Founder)inPaul Hartung(Director)in
BoardAmy Salzhauer(Director)in
Co-investorsGood Growth CapitalDorm RoomNina CapitalIAG Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.